Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2871 of 6351
-
School program aims to ease teen depression in pakistan
Symptom relief OngoingThis study aims to test the effectiveness of a stepped-care model to reduce depressive symptoms in adolescents in school settings in Pakistan. The study will examine whether the universal intervention, delivered by non-specialists, can reduce depressive symptoms in adolescents af…
Sponsor: Global Institute of Human Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Phone buddies fight HIV stigma in ethiopian teens
Symptom relief Recruiting nowAdvances in HIV care and treatment turned a once deadly disease into a chronic condition where people living with HIV, including perinatally HIV acquired children, can now lead a healthy life and live longer with their highly effective antiretroviral therapy. Despite the advancem…
Sponsor: Lund University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Could probiotics ease arthritis pain? new study investigates
Disease control Recruiting nowThe goal of this clinical study is to collect data on the effect of probiotic administration on clinical outcomes in rheumatoid arthritis patients. Participants will: * Have a 6-week daily administration of a probiotic * Collect fecal samples every other day during the first 3 …
Sponsor: Ancilia Biosciences • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could a single blood thinner after stents be safer?
Disease control Recruiting nowRationale: Dual antiplatelet therapy, consisting of aspirin and a P2Y12-inhibitor, reduces the risk of stent-related and non-stent-related ischemic events after percutaneous coronary intervention (PCI). However, this therapy is also associated with a higher risk of bleeding. Give…
Phase 4 • Sponsor: J.P.S Henriques • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New TB vaccine trial aims to shield millions
Vaccine OngoingThis is a randomized, observer-blind, positive-controlled study. There will be 2 treatment groups (Group A and B). In each treatment group, 18 participants will be randomly assigned to receive either the investigational vaccine (Dose A or Dose B of Ad5-105K) or a placebo in a rat…
Phase 1 • Sponsor: CanSino Biologics Inc. • Aim: Vaccine
Last updated Jun 27, 2026 12:25 UTC
-
New drug may cut opioid use for broken rib pain
Symptom relief By invitation onlyRib fractures cause a significant amount of pain and are associated with an increased risk of lung infections, long hospitalization, and increased cost. Effective pain control is the cornerstone of management to improve lung function and minimize complications. Most often this is…
Phase 4 • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Could a gentle zap to the forehead protect the brain after injury?
Knowledge-focused Recruiting nowThe purpose of this research is to demonstrate that mild stimulation of a nerve (trigeminal nerve) in the head can modulate blood flow in the brain. The modulated blood flow will restore the flow of cerebrospinal fluid (CSF) and this in turn can help improve waste clearance in th…
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Can talk therapy ease the mental burden of HIV? new study tests two approaches
Symptom relief OngoingThis is a randomized controlled trial comparing Acceptance and Commitment Therapy (ACT) and Cognitive Behavioral Therapy (CBT) for HIV/AIDS patients at Sheikh Zayed Hospital. 72 adults, aged 18-40 on ART will be randomized to CBT group (n=24), ACT group (n=24), or control group (…
Sponsor: Sadia Batool • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can mindfulness and parent talks keep college drinking in check?
Disease control CompletedAll students who enroll in the study will receive an efficacious counselor-delivered brief motivational intervention. The intervention is based in principles of motivational interviewing. Students complete a baseline assessment on their alcohol use and alcohol-related consequence…
Sponsor: University of Massachusetts, Amherst • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Music as medicine: new study tests tunes to tame chemo side effects
Symptom relief By invitation onlyThis study aims to evaluate the feasibility and potential benefits of music therapy in patients with breast cancer undergoing adjuvant chemotherapy. Breast cancer patients often experience significant physical and psychological symptoms during treatment, including anxiety, fatig…
Sponsor: Istituto di Studi Superiori Musicali (ISSM) Conservatorio Antonio Vivaldi di Alessandria • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Probiotic trial aims to ease perimenopause brain fog and mood swings
Symptom relief Recruiting nowRecent evidence suggests multi-strain probiotics containing Lactobacillus rhamnosus and Bifidobacterium longum have been found to enhance emotional processing and reduce salience to negative cues in studies involving people with mood disorders, as well as improve cognitive functi…
Sponsor: University of Oxford • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Can VR keep teens off vapes? yale tests a new approach
Prevention By invitation onlyThis study will examine E-Invite Only VR, a novel school-based universal e-cigarette prevention intervention that uses virtual reality (VR) to deliver prevention and emotion regulation skills-building content to middle school students in real-world classrooms. In Phase 1, investi…
Sponsor: Yale University • Aim: Prevention
Last updated Jun 27, 2026 08:14 UTC
-
Can a headset zap cannabis cravings? new study tests At-Home brain stimulation
Disease control Recruiting nowThe purpose of this sham-controlled pilot randomized controlled trial (RCT) is to evaluate the feasibility, safety, and preliminary efficacy of a one-month intervention consisting of 20 home-based active or sham RS-tDCS sessions paired with audio track guided mindfulness meditati…
Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for rare gut disease? drug trial launches for APECED enteritis
Disease control Recruiting nowBackground: Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), also known as Autoimmune polyendocrine syndrome type-1 (APS-1), is a disease that causes the immune system to attack parts of a person's body. In some people, APECED attacks the small intestine;…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC
-
Free groceries delivered to pregnant moms may reduce preterm births
Disease control Recruiting nowMedically tailored groceries (MTG), involving grocery items to be prepared at home, selected by a nutritional professional based on a treatment plan, is a growing approach adopted by healthcare systems to address food insecurity in their patient populations, a leading contributio…
Sponsor: Case Western Reserve University • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New drug aims to shrink swollen glands in rare disease
Disease control OngoingThe goal of this clinical trial is to learn if efgartigimod can treat IgG4-related disease in adults. The main questions it aims to answer are: In patients with IgG4-related disease, does treatment with efgartigimod reduce the volume of the: * lacrimal gland(s) and/or * salivar…
Phase 2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Which COVID vaccine works best? new study pits novavax against pfizer
Knowledge-focused OngoingCIRV2 is a Phase IV randomized, open-label, trial of FDA-approved COVID-19 and/or influenza vaccines (no more than minimal risk) with longitudinal follow-up. In 2025 CIRV2 will compare immunogenicity and reactogenicity of the recombinant Novavax COVID-19 vaccine and the mRNA Pfiz…
Phase 4 • Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
HIV weight loss drug trial aims to cut inflammation
Disease control CompletedThis is a prospective cohort study of 12 overweight (with one or more weight-related condition) or obese adults with well controlled HIV-1 on antiretroviral therapy (ART). An initial dose of tirzepatide (TZP) 2.5 mg subcutaneous (SQ) once weekly will be given, escalated by 2.5 mg…
Phase 2 • Sponsor: University of Hawaii • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Music as medicine: new study tests if tunes can soothe Post-Stroke anxiety
Symptom relief Recruiting nowNumerous studies have highlighted how individualized music listening favors motor, cognitive, and emotional recovery in post-stroke patients, stimulating neuroplasticity and cerebral connectivity. However, gaps persist regarding the standardization of protocols and the neural mec…
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Mind-Body boost: new therapy may ease scoliosis struggles in teens
Symptom relief Recruiting nowThe goal of this randomised clinical trial is to evaluate whether adding Basic Body Awareness Therapy (BBAT) to scoliosis-specific exercises can improve body awareness, quality of life and scoliosis-speficic outcomes in adolescents aged 10-17 years with adolescent idiopathic scol…
Sponsor: Gözde Yagci (Gür) • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC